Krystal Biotech (KRYS) Share-based Compensation (2016 - 2026)
Krystal Biotech recorded quarterly Share-based Compensation of $13.6 million in Q1 2026, down 1.13% quarter-over-quarter from $13.8 million in Q4 2025, and up 0.97% year-over-year from $13.5 million in Q1 2025.
Krystal Biotech's Share-based Compensation history runs 11 years deep, the most recent figure standing at $13.6 million for Q1 2026.
- In Q1 2026, Share-based Compensation rose 0.97% year-over-year to $13.6 million; the TTM figure through Mar 2026 stood at $54.6 million (up 2.51% YoY), while the FY2025 annual figure was $54.5 million, up 10.97% from the prior year.
- Share-based Compensation came in at $13.6 million for Q1 2026 at Krystal Biotech, down from $13.8 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $14.1 million in Q2 2025 to a low of $6.4 million in Q1 2022.
- A 5-year average of $11.2 million and a median of $11.3 million in 2023 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation soared 177.99% in 2022 and fell 10.9% in 2024, its largest moves.
- Krystal Biotech's Share-based Compensation stood at $9.6 million in 2022, then grew by 3.15% to $9.9 million in 2023, then surged by 35.55% to $13.4 million in 2024, then grew by 3.05% to $13.8 million in 2025, then decreased by 1.13% to $13.6 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $13.6 million, $13.8 million, and $13.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Krystal Biotech | 9.05 Bn | 8.23 Bn | 110.03 Mn | 13.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.61 Mn |
| Mar 31, 2026 | 13.61 Mn |
| Dec 31, 2025 | 13.76 Mn |
| Dec 31, 2025 | 13.76 Mn |
| Sep 30, 2025 | 13.15 Mn |
| Sep 30, 2025 | 13.15 Mn |
| Jun 30, 2025 | 14.12 Mn |
| Jun 30, 2025 | 14.12 Mn |
| Mar 31, 2025 | 13.48 Mn |
| Mar 31, 2025 | 13.48 Mn |
| Dec 31, 2024 | 13.36 Mn |
| Dec 31, 2024 | 13.36 Mn |
| Sep 30, 2024 | 13.32 Mn |
| Sep 30, 2024 | 13.32 Mn |
| Jun 30, 2024 | 13.16 Mn |
| Jun 30, 2024 | 13.16 Mn |
| Mar 31, 2024 | 9.30 Mn |
| Mar 31, 2024 | 9.30 Mn |
| Dec 31, 2023 | 9.85 Mn |
| Dec 31, 2023 | 9.85 Mn |
| Sep 30, 2023 | 8.31 Mn |
| Sep 30, 2023 | 8.31 Mn |
| Jun 30, 2023 | 11.33 Mn |
| Jun 30, 2023 | 11.33 Mn |
| Mar 31, 2023 | 10.44 Mn |
| Mar 31, 2023 | 10.44 Mn |
| Dec 31, 2022 | 9.55 Mn |
| Dec 31, 2022 | 9.55 Mn |
| Sep 30, 2022 | 9.06 Mn |
| Sep 30, 2022 | 9.06 Mn |
| Jun 30, 2022 | 8.19 Mn |
| Jun 30, 2022 | 8.19 Mn |
| Mar 31, 2022 | 6.43 Mn |
| Mar 31, 2022 | 6.43 Mn |
| Dec 31, 2021 | 5.15 Mn |
| Dec 31, 2021 | 5.15 Mn |
| Sep 30, 2021 | 3.67 Mn |
| Sep 30, 2021 | 3.67 Mn |
| Jun 30, 2021 | 4.20 Mn |
| Jun 30, 2021 | 4.20 Mn |
| Mar 31, 2021 | 2.31 Mn |
| Mar 31, 2021 | 2.31 Mn |
| Dec 31, 2020 | 570,000.00 |
| Dec 31, 2020 | 570,000.00 |
| Sep 30, 2020 | 1.36 Mn |
| Sep 30, 2020 | 1.36 Mn |
| Jun 30, 2020 | 807,000.00 |
| Jun 30, 2020 | 807,000.00 |
| Mar 31, 2020 | 539,000.00 |
| Mar 31, 2020 | 539,000.00 |
| Dec 31, 2019 | 323,000.00 |
| Dec 31, 2019 | 323,000.00 |
| Sep 30, 2019 | 278,000.00 |
| Sep 30, 2019 | 278,000.00 |
| Jun 30, 2019 | 252,000.00 |
| Jun 30, 2019 | 252,000.00 |
| Mar 31, 2019 | 313,000.00 |
| Mar 31, 2019 | 313,000.00 |
| Dec 31, 2018 | 302,000.00 |
| Dec 31, 2018 | 302,000.00 |
| Sep 30, 2018 | 168,000.00 |
| Sep 30, 2018 | 168,000.00 |
| Jun 30, 2018 | 110,000.00 |
| Jun 30, 2018 | 110,000.00 |
| Mar 31, 2018 | 65,000.00 |
| Mar 31, 2018 | 65,000.00 |
| Dec 31, 2017 | 58,000.00 |
| Dec 31, 2017 | 58,000.00 |
| Sep 30, 2017 | 54,000.00 |
| Sep 30, 2017 | 54,000.00 |
| Jun 30, 2017 | 44,000.00 |
| Jun 30, 2017 | 44,000.00 |
| Mar 31, 2017 | 91,000.00 |
| Mar 31, 2017 | 91,000.00 |
| Dec 31, 2016 | 26,000.00 |
| Dec 31, 2016 | 26,000.00 |
| Sep 30, 2016 | 4,000.00 |
| Sep 30, 2016 | 4,000.00 |